Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart baby bed mat could track newborn health without wires

NCT ID NCT06679127

Knowledge-focused Sponsor: Anna Axelin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a new bed monitoring device for newborns in a hospital. The device measures heart rate, breathing, and movements, and tries to detect sleep stages. 75 healthy newborns used the device for two hours, and its readings were compared to standard monitors. Parents and healthcare workers also gave feedback on how easy and useful the device was.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
newborn bed monitoring device
What this could lead to
If successful, this device could offer a non-invasive way to monitor newborns' vital signs and sleep patterns, potentially improving care in hospitals.
What could go wrong
This is a small pilot study with only 75 participants, so results may not apply to all newborns. The device's accuracy and usability are still being tested, and it may not work as well as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

75 people

The number who actually took part.

Started

May 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All parents will be informed about the study when moving from labour ward to postnatal ward. Newborns participating in the study will be approximately 1-3 days old. Parents of the participating newborns will be informed about the study and invited to participate to the study part for parents. All healthcare professionals working in the study unit during the newborn data collection are able to participate in the study part for healthcare professionals.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for newborns: * received informed consent from both parents/guardians * newborn is treated in the Ward of families and newborns * newborn is having normal health status without ongoing additional treatments. No exclusion criteria Inclusion criteria for parents: * being a parent of newborn participating in the study with bed monitoring device * being able to participate in Finnish. No exclusion criteria Inclusion criteria for healthcare professionals: * being a healthcare professional working with newborns * being able to participate in Finnish. No exclusion criteria

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Validation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Validation

Contacts and locations

Locations

  • Turku University Hospital

    Turku, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.